Back to search

France· FR:67319215

OPRYMEA 2,1 mg, comprimé à libération prolongée

A pramipexole product containing dichlorhydrate de pramipexole monohydraté, registered in France by KRKA (SLOVENIE), on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N04BC05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedOPRYMEA 2,1 mg, comprimé à libération…ATCN04BC05REGISTER NO.FR:67319215PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Pramipexole is registered in 18 of 19 countries.

Countries holding a registration under ATC N04BC05 (pramipexole), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Pramipexole · ATC N04BC05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pramipexole costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.28 in United States to $5.68 in Switzerland — a ×20 gap.

  • France: $1.32 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Pramipexole · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.68
  • IT Italy$2.62
  • FR France$1.32
  • US United States$0.28 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DICHLORHYDRATE DE PRAMIPEXOLE MONOHYDRATÉ
Manufacturer
KRKA (SLOVENIE)
Country
France (FR)
ATC code
N04BC05
ATC class
Pramipexole
Defined daily dose
2.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400927622922
    plaquette(s) thermoformée(s) polyamide aluminium polyéthylène de 30 comprimé(s)
    EUR 25.3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

197 interactions on record for pramipexole.

Graded by severity as the source publishes them — 51 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pramipexole · interactions on record

197 records

  • 51 moderate
  • 3 minor
  • 138 info

Most severe, free to view

  • CimetidineA02BA01moderate
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pramipexole in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pramipexole products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Calmolan, Calmolan Retard
  • Belgium · Pramipexol, Pramipexol Eg
  • Bulgaria · Parson, Peximyr 0,18 Mg
  • Cyprus · Medopexol, Rapexole
  • Czechia · Calmolan, Glepark
  • Germany · Glepark, Pexapral
  • Denmark · Glepark, Mariprax
  • Spain · Pramipexol Aurovitas, Pramipexol Aurovitas Spain
  • Finland · Pramipexol, Pramipexol Stada
  • United Kingdom (Northern Ireland) · Pipexus, Pramipexole Glenmark Pharmaceuticals Europe
  • Greece · Glepark, Mariprax
  • Croatia · Pramipeksol Pliva
  • Hungary · Calmolan, Erimexol
  • Ireland · Miramel
  • Iceland · Mirapexin, Oprymea
  • Italy · Pramiperal, Pramipexolo Aurobindo
  • Liechtenstein · Mirapexin, Pramipexole Teva
  • Lithuania · Pramipexole Orion
  • Luxembourg · Pramipexol Eg, Pramipexole Eg
  • Latvia · Pramipexole Elvim, Pramipexole Orion
  • Malta · Pramipexole Aurobindo
  • Netherlands · Glepark, Pramipexol Aurobindo
  • Norway · Mirapexin, Oprymea
  • Portugal · Pramipexol Aurobindo, Pramipexol Azevedos
  • Romania · Pramipexol Arena, Pramipexol Stada
  • Sweden · Calmolan, Derinik
  • Slovakia · Glepark, Pramipexol Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d28dec6f-5f94-42f7-a673-74cdf4ba7135
GET /v1/drugs/d28dec6f-5f94-42f7-a673-74cdf4ba7135?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67319215",
  "date_amm": "2013-11-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/08/469",
  "substance": "DICHLORHYDRATE DE PRAMIPEXOLE MONOHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about pramipexole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.